Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer.
Katsurada M, Nagano T, Tachihara M, Kiriu T, Furukawa K, Koyama K, Otoshi T, Sekiya R, Hazama D, Tamura D, Nakata K, Katsurada N, Yamamoto M, Kobayashi K, Nishimura Y.
Katsurada M, et al. Among authors: katsurada n.
Anticancer Res. 2019 Feb;39(2):815-825. doi: 10.21873/anticanres.13180.
Anticancer Res. 2019.
PMID: 30711962